CASP4 and osteoarthritis: The changes in expression of the DEGs listed in the osteoarthritis pathway included strong down-regulation of cartilage matrix molecules (COL2A1, MATN3, and ACAN) and up-regulation of matrix proteases (ADAMTS5 and MMP13) and apoptosis-related molecules (CASP4) (Figure 2).